Apolipoprotein A-I mimetic peptides: Potential role in atherosclerosis management

Trends in Cardiovascular Medicine

Volumn 15, Issue 8, 2005, Pages 291-296

  Shah, Prediman K ^a,b,c   Chyu, Kuang Yuh ^a,b,c  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; D4F PEPTIDE; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PEPTIDE DERIVATIVE; PRAVASTATIN; UNCLASSIFIED DRUG;

ATHEROMA; ATHEROSCLEROSIS; CLINICAL TRIAL; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG MECHANISM; GENE TRANSFER; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; LIPID TRANSPORT; MORBIDITY; MORTALITY; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RABBIT; RANDOMIZATION; REVIEW; SEQUENCE HOMOLOGY; TRANSGENIC ANIMAL; ULTRASOUND;

ANIMALS; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; HUMANS; LIPOPROTEINS, HDL; PEPTIDES;

EID: 27744543480     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2005.09.003     Document Type: Review

References (39)

1. S Ameli, A Hultgardh-Nilsson, and B Cercek Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits Circulation 90 1994 1935 1941
2. EA Amsterdam Benefit on atherosclerosis of adding niacin in patients with low HDL-cholesterol taking a statin Prev Cardiol 8 2005 130
3. G Assmann, and AM Gotto HDL cholesterol and protective factors in atherosclerosis Circulation 109 2004 III8 III14
4. P Barter HDL: a recipe for longevity Atheroscler Suppl 5 2004 25 31
5. C Bergt, S Pennathur, and X Fu The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport Proc Natl Acad Sci U S A 101 2004 13032 13037
6. HB Brewer Increasing HDL cholesterol levels N Engl J Med 350 2004 1491 1494
7. BG Brown, XQ Zhao, and A Chait Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease N Engl J Med 345 2001 1583 1592
8. G Chiesa, and CR Sirtori Apolipoprotein A-I(Milano): Current perspectives Curr Opin Lipidol 14 2003 159 163
9. G Datta, RF Epand, and RM Epand Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity J Biol Chem 279 2004 26509 26517
10. M de la Llera Moya, V Atger, and JL Paul A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer Arterioscler Thromb 14 1994 1056 1065
11. S Fazio, and MF Linton The role of fibrates in managing hyperlipidemia: Mechanisms of action and clinical efficacy Curr Atheroscler Rep 6 2004 148 157
12. JS Forrester, R Makkar, and PK Shah Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: An update for clinicians Circulation 111 2005 1847 1854
13. N Fournier, M de la Llera Moya, and BF Burkey Role of HDL phospholipid in efflux of cell cholesterol to whole serum: Studies with human apoA-I transgenic rats J Lipid Res 37 1996 1704 1711
14. DW Garber, G Datta, and M Chaddha A new synthetic class a amphipathic peptide analogue protects mice from diet-induced atherosclerosis J Lipid Res 42 2001 545 552
15. KF Kozarsky, MH Donahee, and JM Glick Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse Arterioscler Thromb Vasc Biol 20 2000 721 727
16. X Li, KY Chyu, and JR Neto Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice Circulation 110 2004 1701 1705
17. P Linsel-Nitschke, and AR Tall HDL as a target in the treatment of atherosclerotic cardiovascular disease Nat Rev Drug Discov 4 2005 193 205
18. R Mukherjee, J Strasser, and L Jow RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo Arterioscler Thromb Vasc Biol 18 1998 272 276
19. M Navab, GM Anantharamaiah, and S Hama Oral administration of an Apo A-I mimetic Peptide synthesized from d-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol Circulation 105 2002 290 292
20. M Navab, S Hama, and G Hough Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice Circulation 108 2003 1735 1739
21. M Navab, GM Ananthramaiah, and ST Reddy The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL J Lipid Res 45 2004 993 1007
22. M Navab, GM Anantharamaiah, and ST Reddy Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice Circulation 109 2004 3215 3220
23. M Navab, GM Anantharamaiah, and ST Reddy Apolipoprotein A-I mimetic peptides Arterioscler Thromb Vasc Biol 25 2005 1325 1331
24. M Navab, GM Anantharamaiah, and S Hama D-4F and statins synergize to render HDL anti-inflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E null mice Arterioscler Thromb Vasc Biol 25 2005 1426 1432
25. M Navab, GM Anantharamaiah, and ST Reddy An oral apoJ peptide renders HDL anti-inflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice Arterioscler Thromb Vasc Biol 25 2005 1932 1937
26. M Navab, GM Anantharamaiah, and ST Reddy Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice Circ Res 97 6 2005 524 532
27. SE Nissen, T Tsunoda, and EM Tuzcu Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial JAMA 290 2003 2292 2300
28. J Ou, Z Ou, and DW Jones L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease Circulation 107 2003 2337 2341
29. Z Ou, J Ou, and AW Ackerman L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells Circulation 107 2003 1520 1524
30. AT Remaley, F Thomas, and JA Stonik Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA-1 dependant and an ABCA-I independent pathway J Lipid Res 44 2003 828 836
31. PK Shah, J Nilsson, and S Kaul Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice Circulation 97 1998 780 785
32. PK Shah, S Kaul, and J Nilsson Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: An idea whose time for testing is coming, part II Circulation 104 2001 2498 2502
33. PK Shah, S Kaul, and J Nilsson Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: An idea whose time for testing is coming, part I Circulation 104 2001 2376 2383
34. PK Shah, J Yano, and O Reyes High-dose recombinant apolipoprotein A-I(Milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization Circulation 103 2001 3047 3050
35. RK Tangirala, K Tsukamoto, and SH Chun Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice Circulation 100 1999 1816 1822
36. UK Consensus Role of fibrates in reducing coronary risk Curr Med Res Opin 20 2004 241 247
37. BJ Van Lenten, AC Wagner, and GM Anantharamaiah Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide Circulation 106 2002 1127 1132
38. BJ Van Lenten, AC Wagner, and M Navab D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes Circulation 110 2004 3252 3258
39. JM Wallace, M Schwarz, and P Coward Effects of peroxisome proliferator-activated receptor {alpha}/{delta} agonists on HDL-cholesterol in vervet monkeys J Lipid Res 46 2005 1009 1016